Table of Contents
ISRN Structural Biology
Volume 2013, Article ID 373516, 12 pages
http://dx.doi.org/10.1155/2013/373516
Research Article

2D-QSAR, Docking Studies, and In Silico ADMET Prediction of Polyphenolic Acetates as Substrates for Protein Acetyltransferase Function of Glutamine Synthetase of Mycobacterium tuberculosis

1Department of Biochemistry and Microbiology, V. P. Chest Institute, University of Delhi, Delhi 110 007, New Delhi, India
2Department of Chemistry, University of Delhi, Delhi 110 007, New Delhi, India
3Department for Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Mohali, Punjab 160062, India
4Dr. B.R. Ambedakar Centre for Biomedical Research, University of Delhi, Delhi 110 007, India

Received 30 November 2012; Accepted 20 December 2012

Academic Editors: M. Espinoza-Fonseca and D. D. Leonidas

Copyright © 2013 Prija Ponnan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. G. Raj, V. S. Parmar, S. C. Jain et al., “Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part 4: hyperbolic activation of rat liver microsomal nadph-cytochrome C reductase by the novel acetylator 7,8-diacetoxy-4-methylcoumarin,” Bioorganic & Medicinal Chemistry, vol. 7, no. 2, pp. 369–373, 1999. View at Publisher · View at Google Scholar
  2. H. G. Raj, V. S. Parmar, S. C. Jain et al., “Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part 7: assay and characterization of 7,8-diacetoxy-4-methylcoumarin:protein transacetylase from rat liver microsomes based on the irreversible inhibition of cytosolic glutathione S-Transferase,” Bioorganic & Medicinal Chemistry, vol. 8, no. 7, pp. 1707–1712, 2000. View at Publisher · View at Google Scholar
  3. P. Khurana, R. Kumari, P. Vohra et al., “Acetoxy drug: protein transacetylase catalyzed activation of human platelet nitric oxide synthase by polyphenolic peracetates,” Bioorganic & Medicinal Chemistry, vol. 14, pp. 575–583, 2006. View at Google Scholar
  4. H. G. Raj, R. Kumari, S. Bansal et al., “Novel function of calreticulin: characterization of calreticulin as a transacetylase-mediating protein acetylator independent of acetyl CoA using polyphenolic acetates,” Pure and Applied Chemistry, vol. 78, pp. 985–992, 2006. View at Publisher · View at Google Scholar
  5. Seema, R. Kumari, G. Gupta et al., “Characterization of protein transacetylase from human placenta as a signaling molecule calreticulin using polyphenolic peracetates as the acetyl group donors,” Cell Biochemistry and Biophysics, vol. 47, pp. 53–64, 2007. View at Google Scholar
  6. E. Kohli, M. Gaspari, H. G. Raj et al., “Acetoxy drug: protein transacetylase of buffalo liver—characterization and mass spectrometry of the acetylated protein product,” Biochimica Et Biophysica Acta, vol. 1698, pp. 55–66, 2004. View at Publisher · View at Google Scholar
  7. S. Bansal, M. Gaspari, H. G. Raj et al., “Calreticulin transacetylase mediates the acetylation of nitric oxide synthase by polyphenolic acetate,” Applied Biochemistry and Biotechnology, vol. 144, pp. 37–45, 2008. View at Publisher · View at Google Scholar
  8. G. Gupta, A. S. Baghel, S. Bansal et al., “Establishment of glutamine synthetase of Mycobacterium smegmatis as a protein acetyltransferase utilizing polyphenolic acetates as the acetyl group donors,” Journal of Biochemistry, vol. 144, no. 6, pp. 709–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Baghel, R. Tandon, G. Gupta et al., “Characterization of protein acyltransferase function of recombinant purified GlnA1 from Mycobacterium tuberculosis: a moon lighting property,” Microbiological Research, vol. 166, pp. 662–672, 2011. View at Publisher · View at Google Scholar
  10. G. R. Hirschfield, M. McNeil, and P. J. Brennan, “Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis,” Journal of Bacteriology, vol. 172, no. 2, pp. 1005–1013, 1990. View at Google Scholar · View at Scopus
  11. G. Harth, D. L. Clemens, M. A. Horwitz et al., “Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, pp. 9342–9346, 1994. View at Publisher · View at Google Scholar
  12. O. W. Griffith and A. Meister, “Differential inhibition of glutamine and γ-glutamylcysteine synthetases by α-alkyl analogs of methionine sulfoximine that induce convulsions,” Journal of Biological Chemistry, vol. 253, no. 7, pp. 2333–2338, 1978. View at Google Scholar · View at Scopus
  13. B. Lejczak, H. Starzemska, and P. Mastalerz, “Inhibition of rat liver glutamine synthetase by phosphonic analogues of glutamic acid,” Experientia, vol. 37, no. 5, pp. 461–462, 1981. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Tandon, P. Ponnan, N. Aggarwal et al., “Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships,” Journal of Antimicrobial Chemotherapy, vol. 66, pp. 2543–2555, 2011. View at Publisher · View at Google Scholar
  15. A. Kathuria, A. Gupta, N. Priya et al., “Specificities of calreticulin transacetylase to acetoxy derivatives of 3-alkyl-4-methylcoumarins: effect on the activation of nitric oxide synthase,” Bioorganic & Medicinal Chemistry, vol. 17, pp. 1550–1556, 2009. View at Publisher · View at Google Scholar
  16. Hyperchem Release8. Windows Molecular Modelling System, Hypercube, Inc. and Autodesk, Inc. Developed by Hypercube, Inc.
  17. A. Golbraikh and A. Tropsha, “Beware of q2!,” Journal of Molecular Graphics and Modelling, vol. 20, no. 4, pp. 269–276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Tropsha, P. Gramatica, and V. K. Gombar, “The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models,” QSAR and Combinatorial Science, vol. 22, no. 1, pp. 69–77, 2003. View at Google Scholar · View at Scopus
  19. W. J. Egan, K. M. Merz, and J. J. Baldwin, “Prediction of drug absorption using multivariate statistics,” Journal of Medicinal Chemistry, vol. 43, no. 21, pp. 3867–3877, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Cheng and K. M. Merz, “Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships,” Journal of Medicinal Chemistry, vol. 46, no. 17, pp. 3572–3580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. W. J. Egan and G. Lauri, “Prediction of intestinal permeability,” Advanced Drug Delivery Reviews, vol. 54, no. 3, pp. 273–289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. S. L. Dixon and K. M. Merz, “One-dimensional molecular representations and similarity calculations: methodology and validation,” Journal of Medicinal Chemistry, vol. 44, no. 23, pp. 3795–3809, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. G. Susnow and S. L. Dixon, “Use of robust classification techniques for the prediction of human cytochrome P450 2D6 inhibition,” Journal of Chemical Information and Computer Sciences, vol. 43, pp. 1308–1315, 2003. View at Google Scholar
  24. A. Cheng and S. L. Dixon, “In silico models for the prediction of dose-dependent human hepatotoxicity,” Journal of Computer-Aided Molecular Design, vol. 17, no. 12, pp. 811–823, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Hetényi and D. Spoelvander, “Efficient docking of peptides to proteins without prior knowledge of the binding site,” Protein Science, vol. 11, pp. 1729–1737, 2002. View at Publisher · View at Google Scholar
  26. G. M. Morris, D. S. Goodsell, R. S. Halliday et al., “Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function,” Journal of Computational Chemistry, vol. 19, no. 14, pp. 1639–1662, 1998. View at Google Scholar · View at Scopus
  27. W. W. Krajewski, A. T. Jones, S. L. Mowbray et al., “Structure of Mycobacterium tuberculosis glutamine synthetase in complex with a transition-state mimic provides functional insights,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, pp. 10499–10504, 2005. View at Publisher · View at Google Scholar
  28. M. F. Sanner, B. S. Duncan, C. J. Carrillo et al., “Proteinmorphosis: a mechanical model for protein conformational changes,” in Proceedings of the Pacific Symposium in Biocomputing (PSB '99), pp. 401–412, Big Island, Hawaii, USA, 1999.
  29. T. J. A. Ewing and I. D. Kuntz, “Critical evaluation of search algorithms for automated molecular docking and database screening,” Journal of Computational Chemistry, vol. 18, no. 9, pp. 1175–1189, 1997. View at Google Scholar · View at Scopus
  30. D. A. Dougherty, “Cation-π interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp,” Science, vol. 271, no. 5246, pp. 163–168, 1996. View at Google Scholar · View at Scopus
  31. A. T. Balaban, “Highly discriminating distance-based topological index,” Chemical Physics Letters, vol. 89, pp. 399–404, 1982. View at Publisher · View at Google Scholar
  32. D. Mandloi, S. Joshi, P. V. Khadikar et al., “QSAR study on the antibacterial activity of some sulfa drugs: building blockers of Mannich bases,” Bioorganic & Medicinal Chemistry Letters, vol. 15, pp. 405–411, 2005. View at Publisher · View at Google Scholar
  33. S. C. Basak, D. P. Gieschen, D. K. Harriss, and V. R. Magnuson, “Physicochemical and topological correlates of the enzymatic acetyltransfer reaction,” Journal of Pharmaceutical Sciences, vol. 72, no. 8, pp. 934–937, 1983. View at Google Scholar · View at Scopus
  34. P. Singh, P. Ponnan, S. Krishnan et al., “Protein acyltransferase function of purified calreticulin. Part 1: characterization of propionylation of protein utilizing propoxycoumarin as the propionyl group donor,” Journal of Biochemistry, vol. 147, no. 5, pp. 625–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Chen, R. Sprung, Y. Tang et al., “Lysine propionylation and butyrylation are novel post-translational modifications in histones,” Molecular & Cellular Proteomics, vol. 6, pp. 812–819, 2007. View at Publisher · View at Google Scholar
  36. J. H. Williams, “The molecular electric quadrupole moment and solid-state architecture,” Accounts of Chemical Research, vol. 26, pp. 593–598, 1993. View at Publisher · View at Google Scholar
  37. M. Dennis, J. Giraudat, F. Kotzyba-Hibert et al., “Amino acids of the torpedo marmorata acetylcholine receptor α subunit labeled by a photoaffinity ligand for the acetylcholine binding site,” Biochemistry, vol. 27, no. 7, pp. 2346–2357, 1988. View at Google Scholar · View at Scopus
  38. P. D. Leeson, R. Baker, R. W. Carling et al., “Amino acid bioisosteres: design of 2-quinolone derivatives as glycine-site N-methyl-D-aspartate receptor antagonists,” Bioorganic & Medicinal Chemistry Letters, vol. 3, pp. 299–304, 1993. View at Publisher · View at Google Scholar
  39. B. Yang, J. Wright, M. E. Eldefrawi, S. Pou, and A. D. MacKerell, “Conformational, aqueous solvation, and pK(a) contributions to the binding and activity of cocaine, WIN 32065-2, and the WIN vinyl analog,” Journal of the American Chemical Society, vol. 116, no. 19, pp. 8722–8732, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. S. H. Liaw, I. Kuo, and D. Eisenberg, “Discovery of the ammonium substrate site on glutamine synthetase, a third cation binding site,” Protein Science, vol. 4, no. 11, pp. 2358–2365, 1995. View at Google Scholar · View at Scopus
  41. K. Palm, P. Stenberg, K. Luthman, and P. Artursson, “Polar molecular surface properties predict the intestinal absorption of drugs in humans,” Pharmaceutical Research, vol. 14, no. 5, pp. 568–571, 1997. View at Publisher · View at Google Scholar · View at Scopus